Clinical Trial Update: Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203) [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating Andriol Testocaps for symptomatic late-onset hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Late-onset Hypogonadism

Drugs mentioned

• Andriol Testocaps (testosterone undecanoate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypogonadism, Androgens | Phase 2 | Status: COMPLETED